Literature DB >> 15234016

Vasculitis in systemic lupus erythematosis.

Kenneth T Calamia1, Maria Balabanova.   

Abstract

Vasculitis in connective tissue diseases is not an uncommon complication. Vasculitis complicates both rheumatoid arthritis and systemic lupus erythematosis (SLE) in about 4% of cases. Cutaneous lesions, representing small-vessel involvement, are most common; however, widespread, necrotizing visceral medium-and large-vessel involvement, mimicking primary vasculitic syndromes, may also occur. Connective tissue disease-associated vasculitis is separated from primary vasculitis syndromes in classification schemes. Granulomatous large-vessel disease does not occur in connective tissue diseases, suggesting a different pathogenesis. In most disorders, the etiology of vascular inflammation in not completely understood, but basic pathogenic mechanisms can often be distinguished. The role of immune complexes in the inflammatory manifestations of SLE is recognized, and other pathogenic factors such as antineutrophil cytoplasmic antibodies, common in other vasculitides, are infrequent. A diverse spectrum of clinical features, due to inflammatory involvement of arterial and venous vessels of all sizes, characterize several connective tissue diseases including Behçet's disease and SLE. The recognition of disease manifestations due to vasculitis in these disorders has important implications for treatment and may be critical to reduce morbidity and mortality.

Entities:  

Mesh:

Year:  2004        PMID: 15234016     DOI: 10.1016/j.clindermatol.2003.12.022

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  12 in total

1.  Sudden cardiac death caused by coronary vasculitis.

Authors:  Katsuya Norita; Sofia V de Noronha; Mary N Sheppard
Journal:  Virchows Arch       Date:  2012-02-04       Impact factor: 4.064

2.  Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus.

Authors:  Hiromi Kizu; Hiroaki Dobashi; Tomohiro Kameda; Kentaro Susaki; Masahiko Kawanishi; Toshihiko Ishida
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

Review 3.  Vasculitis in systemic lupus erythematosus.

Authors:  L Barile-Fabris; M F Hernández-Cabrera; J A Barragan-Garfias
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

4.  Endothelial nitric oxide synthase inhibits the development of autoimmune-mediated vasculitis in mice.

Authors:  Trenton R Schoeb; Tambi Jarmi; M John Hicks; Scott Henke; Abolfazl Zarjou; Hitoshi Suzuki; Philip Kramer; Jan Novak; Anupam Agarwal; Daniel C Bullard
Journal:  Arthritis Rheum       Date:  2012-12

5.  Erythema elevatum diutinum in systemic lupus erythematosus.

Authors:  Yung Chan; Chi Chiu Mok; William Yuk Ming Tang
Journal:  Rheumatol Int       Date:  2010-07-23       Impact factor: 2.631

Review 6.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 7.  Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.

Authors:  Tony N Marion; Arnold E Postlethwaite
Journal:  Semin Immunopathol       Date:  2014-08-08       Impact factor: 9.623

8.  Retinal vasculitis in systemic lupus erythematosus: an indication of active disease.

Authors:  Umi Kalthum Md Noh; Aida Zairani A Zahidin; Then Kong Yong
Journal:  Clin Pract       Date:  2012-05-15

9.  Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis.

Authors:  Yunfeng Zhu; Zhenzhen Xue; Lizhe Di
Journal:  Med Sci Monit       Date:  2017-05-26

10.  Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report.

Authors:  Katherine J Donnithorne; Russell W Read; Robert Lowe; Peter Weiser; Randy Q Cron; Timothy Beukelman
Journal:  Pediatr Rheumatol Online J       Date:  2013-06-04       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.